Summary Slide.png (127.62 kB)

Adverse Changes in HbA1c, Body Weight and Insulin Use in People With Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme

Download (127.62 kB)
figure
posted on 08.04.2020 by Jason Gordon, Thomas Danne, Lee Beresford-Hulme, Hayley Bennet, Amarjeet Tank, Christopher Edmonds, Fredrik Thorén, Markus Florian Scheerer, Phil McEwan

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports